Developer docs
API playgroundTry for free, no card

Search company profiles

Q30 Innovations

Full company profile

uuid00026q2

Namestring
Q30 Innovations
Legal namestring
Q30 Innovations, LLC
Websiteurl
q30.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Q30 Innovations is a privately held research and development company founded circa 2011–2012, headquartered in Norwalk, Connecticut, that develops and commercializes the Q-Collar — a non-invasive, FDA-cleared Class 2 medical device worn around the neck that applies controlled pressure to the internal jugular veins to increase intracranial blood volume and reduce brain movement ("brain slosh") during head impacts. The company's product line includes the Q-Collar ($199) for athletes in contact sports (football, soccer, hockey, lacrosse), the Q-Collar Tactical ($249) for military and law enforcement operators, and the Q-Collar Sleeve ($19.99) accessory. The mechanism of action is protected by six issued US utility patents and one design patent, and is supported by more than 25 peer-reviewed clinical studies conducted over 10+ years at institutions including Cincinnati Children's Hospital, Boston Children's Hospital, NorthShore University HealthSystem, West Virginia University, Harvard, University of Toronto, and the Naval Medical Research Center.

The business operates a direct-to-consumer e-commerce channel through q30.com alongside team and institutional sales to professional leagues, collegiate athletic programs, and the US military, plus a Canadian subsidiary (Q30 Sports Canada, Inc.). Revenue is generated entirely through one-time hardware sales — there is no subscription component. Go-to-market is reinforced by an athlete ambassador program featuring active and retired professional athletes across the NFL, MLS, PLL, NHL and NWSL, event sponsorships including the Premier Lacrosse League (as exclusive Brain Injury Protection Partner since 2022) and the Best Ranger Competition, and federally funded military research contracts including a $2.8M US Army Medical Research award in October 2022 and $2.5M in additional federal funds highlighted in April 2024. The company has sold to a cumulative base of 50,000+ athletes since FDA clearance in February 2021 and ships to the US and Canada only.

Short descriptiontext

Q30 Innovations develops and sells the FDA-cleared Q-Collar, a non-invasive neck-worn device that reduces brain movement during head impacts for athletes, military, and tactical operators. The company generates one-time hardware revenue through DTC e-commerce, team sales, and US/Canada channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWestport, United States
HQ citystring
Westport
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
brain protection devices, concussion prevention equipment, FDA-cleared medical devices, traumatic brain injury solutions, sports protective equipment
Industry2 codes
1Safety Accessories & Wearables Retail (Neck Braces, Hydration, Earplugs)
CodeCRAMANALPrimaryYes
2Wearable Accessories & Bands (straps, chargers, cases)
CodeCRACAIAKPrimaryNo
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Brain Protection Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Q-Collar Hardware Sales
TypeHardware Sales
Description

One-time hardware purchase of Q-Collar devices. Q-Collar at $199, Q-Collar Tactical at $249, Q-Collar Sleeve accessories at $19.99. No subscription or recurring revenue model. Revenue generated from direct consumer and team/institutional sales.

q30.com
2Team/Institutional Sales
TypeHardware Sales
Description

Bulk purchases by sports teams, collegiate programs, and military organizations. Includes partnerships with universities (Maryland, Baylor, Michigan State) and military (US Army contracts).

q30.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations
Pricing details3 tiers
1Q-Collar (Standard) - $199.00
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Standard athlete version. Available in multiple colors (Black, Grey, White, Sky Blue, Royal Blue, Navy, Red, Maroon, Orange, Yellow, Gold, Green, Purple, Pink, USA). Sizes SM (11-12), MD (13-14), LG (15-16), XL (17-18). Includes travel case, fit check tool, and owner's guide.

q30.com
2Q-Collar Tactical - $249.00
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Version designed for military/law enforcement operators. Enhanced durability for tactical applications.

q30.com
3Q-Collar Sleeve - $19.99
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Protective sleeve to customize look. Available in 15 colors. Bundle discount available ($5 off with collar, $15 off when buying 3).

q30.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Q-Collar
Description

FDA-cleared brain protection device worn around the neck to help reduce brain movement during impacts

q30.com
+2 more records
Core offering1 text field

Q30 Innovations designs, manufactures, and sells the Q-Collar, an FDA-cleared Class 2 medical device worn around the neck that applies mild internal jugular vein compression to increase intracranial blood volume and reduce brain movement ("brain slosh") during impacts. The company offers a standard Q-Collar for athletes ($199), a Tactical version for military/tactical operators ($249), and color-customizable Q-Collar Sleeve accessories ($19.99), sold via direct-to-consumer e-commerce, team sales programs, retail partners, and government procurement.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 66% reduction in likelihood of brain damage from contact sports over a season of play (clinical trial result)
+3 more records
Product overview1 text field

Q30 Innovations offers a product line centered on the Q-Collar family of brain protection devices. The core offering is the Q-Collar ($199) for athletes, alongside the Q-Collar Tactical ($249) for military operators, with the Q-Collar Sleeve ($19.99) as a color-customizable accessory. All devices apply mild internal jugular vein compression to increase intracranial blood volume, reducing brain movement upon impact to help protect against traumatic brain injury. The products are FDA-cleared Class 2 medical devices backed by over 25 independent clinical studies.

Product and service3 records
1Q-Collar
CategoryBrain Protection Device
Description

FDA-cleared Class 2 medical device worn around the neck that applies mild internal jugular vein compression to increase blood volume in the head, reducing brain movement during impacts. Designed for athletes aged 13+ in contact sports including football, soccer, hockey, and lacrosse. Priced at $199 with multiple colors and sizes.

2Q-Collar Tactical
CategoryBrain Protection Device
Description

Variant of the Q-Collar designed specifically for military and tactical operators, providing additional brain protection against blast waves and blunt force head impacts in operational and training environments. Priced at $249 with enhanced durability.

3Q-Collar Sleeve
CategoryAccessory
Description

Customizable protective sleeve that fits over the Q-Collar, available in 15 colors to match team uniforms and personal preferences. Priced at $19.99 with bundle discounts available.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-23
Description

Official collegiate partnership providing student athletes access to Q-Collar. Includes NIL partnerships and research collaboration.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-23
Description

Official collegiate partnership with Q30 Innovations providing student athletes access to Q-Collar for brain protection.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-23
Description

Official collegiate partnership providing student athletes access to Q-Collar for brain protection.

4Best Ranger Competition
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2024-04-09
Description

Q30 and Best Ranger Competition partnership to help safeguard Army Rangers with Q-Collars during the 40th anniversary competition at Fort Moore, Georgia. Q-Collars worn to reduce TBI risk during high-impact activities.

q30.com
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-10-26
Description

$2.8 million contract awarded by USAMRDC to evaluate safety, effectiveness, and field suitability of Q-Collar to help prevent or reduce TBI from blunt force and blast waves in soldiers.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-03-21
Description

Exclusive Brain Injury Protection Partner of PLL since 2022. Q30 equips athletes across all eight PLL teams with Q-Collars. Partnership includes sponsorship of PLL College Draft (presented by Q-Collar) and Inside Lacrosse High School Rankings.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multiple clinical studies conducted including Human Performance Study, Hockey Study (2014), Football Study (2015-2017), Soccer Study (2016), and tolerability/wearability studies with NFL and CFL players.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Julian Bailes leads research including swine impact safety study and small animal hearing loss studies. Dr. Bailes serves as Q30 Chief Medical Advisor.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborated on large animal effectiveness study (swine impact model) and research validation for Q-Collar technology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration on closed head rotational head impact protocol in swine model.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pre-clinical and clinical research partner for Q-Collar studies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Joseph Fisher (inventor, professor, Chief Scientist at Thornhill Research) contributed to Q-Collar development and research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Investigated whether IJV compression could provide protection against blast-induced TBI in military context.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Developer of protective sports gear using impact-absorbing materials for head, chest, and body protection. Directly comparable to Q30 as a sports protective equipment company serving athletes across multiple contact sports.

TypeDirect peer
Description

Mouthguard company with embedded sensors for impact tracking and concussion prevention in contact sports. Comparable to Q30 as a head-impact protection company with presence in NFL, NHL, and college sports markets.

TypeDirect peer
Description

Sports protective equipment company specializing in mouthguards, gloves, and pads for football, lacrosse, and hockey. Comparable to Q30 in targeting amateur and professional athletes across the same contact sports categories.

4VICIS
TypeDirect peer
Description

Football helmet manufacturer using novel impact-mitigation technology to reduce brain injury. Comparable to Q30 as a head-impact protection company focused on reducing concussion risk in contact sports with FDA/state-of-the-art positioning.

TypeBroad incumbent
Description

Largest US football helmet manufacturer with deep league relationships and broad retail distribution. Comparable to Q30 as an established player in football head protection, but operates at much broader scale as a traditional helmet incumbent.

TypeBroad incumbent
Description

Major football helmet and protective equipment manufacturer serving high school, collegiate, and professional markets. Comparable to Q30 in serving the same football head protection category but with broader product portfolio and incumbency.

TypeEmerging player
Description

Developer of sensor-equipped mouthguards for real-time head impact monitoring and concussion detection. Comparable to Q30 in the head-impact protection space but differentiated through diagnostic/monitoring rather than injury mitigation.

TypeEmerging player
Description

Medical wearable company with FDA-cleared sensor-embedded insoles for diabetic neuropathy and pressure monitoring. Comparable to Q30 as a regulated medical device wearable company targeting specific clinical indications.

TypeOthers
Description

Provider of FDA-cleared neurocognitive testing tools for concussion assessment and management. Comparable to Q30 as a TBI-focused company in the broader brain injury ecosystem, but focused on assessment rather than protection.

TypeBroad incumbent
Description

Football helmet manufacturer known for novel impact attenuation technology and broad NCAA/NFL distribution. Comparable to Q30 as a head protection company targeting the same football market with complementary rather than directly competing technology.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers20 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Q30 Innovations

Brain Protection Medical Devicesq30.com

Q30 Innovations develops and sells the FDA-cleared Q-Collar, a non-invasive neck-worn device that reduces brain movement during head impacts for athletes, military, and tactical operators. The company generates one-time hardware revenue through DTC e-commerce, team sales, and US/Canada channels.

What Q30 Innovations does

Q30 Innovations is a privately held research and development company founded circa 2011–2012, headquartered in Norwalk, Connecticut, that develops and commercializes the Q-Collar — a non-invasive, FDA-cleared Class 2 medical device worn around the neck that applies controlled pressure to the internal jugular veins to increase intracranial blood volume and reduce brain movement ("brain slosh") during head impacts. The company's product line includes the Q-Collar ($199) for athletes in contact sports (football, soccer, hockey, lacrosse), the Q-Collar Tactical ($249) for military and law enforcement operators, and the Q-Collar Sleeve ($19.99) accessory. The mechanism of action is protected by six issued US utility patents and one design patent, and is supported by more than 25 peer-reviewed clinical studies conducted over 10+ years at institutions including Cincinnati Children's Hospital, Boston Children's Hospital, NorthShore University HealthSystem, West Virginia University, Harvard, University of Toronto, and the Naval Medical Research Center.

The business operates a direct-to-consumer e-commerce channel through q30.com alongside team and institutional sales to professional leagues, collegiate athletic programs, and the US military, plus a Canadian subsidiary (Q30 Sports Canada, Inc.). Revenue is generated entirely through one-time hardware sales — there is no subscription component. Go-to-market is reinforced by an athlete ambassador program featuring active and retired professional athletes across the NFL, MLS, PLL, NHL and NWSL, event sponsorships including the Premier Lacrosse League (as exclusive Brain Injury Protection Partner since 2022) and the Best Ranger Competition, and federally funded military research contracts including a $2.8M US Army Medical Research award in October 2022 and $2.5M in additional federal funds highlighted in April 2024. The company has sold to a cumulative base of 50,000+ athletes since FDA clearance in February 2021 and ships to the US and Canada only.

Q30 Innovations firmographics

Firmographics
Name
Q30 Innovations
Legal name
Q30 Innovations, LLC
Website
https://q30.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Q30 Innovations develops and sells the FDA-cleared Q-Collar, a non-invasive neck-worn device that reduces brain movement during head impacts for athletes, military, and tactical operators. The company generates one-time hardware revenue through DTC e-commerce, team sales, and US/Canada channels.
Ownership category
akta.pro rank

Q30 Innovations industry classification

Industry
Product category
Brain Protection Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Safety Accessories & Wearables Retail (Neck Braces, Hydration, Earplugs) (CRAMANAL)
akta.pro secondary industry
Wearable Accessories & Bands (straps, chargers, cases) (CRACAIAK)

Keywords

  • Brain protection devices
  • Concussion prevention equipment
  • FDA-cleared medical devices
  • Traumatic brain injury solutions
  • Sports protective equipment

Where Q30 Innovations is headquartered

Location

Headquarters

HQ city
Westport
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Q30 Innovations business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations

Revenue model

  1. Q-Collar Hardware Sales: One-time hardware purchase of Q-Collar devices. Q-Collar at $199, Q-Collar Tactical at $249, Q-Collar Sleeve accessories at $19.99. No subscription or recurring revenue model. Revenue generated from direct consumer and team/institutional sales.
  2. Team/Institutional Sales: Bulk purchases by sports teams, collegiate programs, and military organizations. Includes partnerships with universities (Maryland, Baylor, Michigan State) and military (US Army contracts).

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goQ-Collar (Standard) - $199.00
Unit PricingPay-as-you-goQ-Collar Tactical - $249.00
Unit PricingPay-as-you-goQ-Collar Sleeve - $19.99

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Q30 Innovations product offering

Product offering

Core offering

Q30 Innovations designs, manufactures, and sells the Q-Collar, an FDA-cleared Class 2 medical device worn around the neck that applies mild internal jugular vein compression to increase intracranial blood volume and reduce brain movement ("brain slosh") during impacts. The company offers a standard Q-Collar for athletes ($199), a Tactical version for military/tactical operators ($249), and color-customizable Q-Collar Sleeve accessories ($19.99), sold via direct-to-consumer e-commerce, team sales programs, retail partners, and government procurement.

Product overview

Q30 Innovations offers a product line centered on the Q-Collar family of brain protection devices. The core offering is the Q-Collar ($199) for athletes, alongside the Q-Collar Tactical ($249) for military operators, with the Q-Collar Sleeve ($19.99) as a color-customizable accessory. All devices apply mild internal jugular vein compression to increase intracranial blood volume, reducing brain movement upon impact to help protect against traumatic brain injury. The products are FDA-cleared Class 2 medical devices backed by over 25 independent clinical studies.

Differentiator

Problem solved

Functional benefit

Brands

  • Q-Collar: FDA-cleared brain protection device worn around the neck to help reduce brain movement during impacts
  • Q-Collar Tactical
  • Q-Collar Sleeve

Products and services

  • Q-Collar FDA-cleared Class 2 medical device worn around the neck that applies mild internal jugular vein compression to increase blood volume in the head, reducing brain movement during impacts. Designed for athletes aged 13+ in contact sports including football, soccer, hockey, and lacrosse. Priced at $199 with multiple colors and sizes.
  • Q-Collar Tactical Variant of the Q-Collar designed specifically for military and tactical operators, providing additional brain protection against blast waves and blunt force head impacts in operational and training environments. Priced at $249 with enhanced durability.
  • Q-Collar Sleeve Customizable protective sleeve that fits over the Q-Collar, available in 15 colors to match team uniforms and personal preferences. Priced at $19.99 with bundle discounts available.

Quantifiable outcome

  • 66% reduction in likelihood of brain damage from contact sports over a season of play (clinical trial result)
  • +3 more outcomes

Companies that use Q30 Innovations

Customer profile

Named customers20 records

Segments4 records

Ideal customer profiles3 records

Q30 Innovations technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Q30 Innovations partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and major.

  • University of MarylandcoreStrategic or Co-development Partner · 23 April 2024Official collegiate partnership providing student athletes access to Q-Collar. Includes NIL partnerships and research collaboration.
  • Baylor UniversitycoreStrategic or Co-development Partner · 23 April 2024Official collegiate partnership with Q30 Innovations providing student athletes access to Q-Collar for brain protection.
  • Michigan State UniversitycoreStrategic or Co-development Partner · 23 April 2024Official collegiate partnership providing student athletes access to Q-Collar for brain protection.
  • Best Ranger CompetitionmajorStrategic or Co-development Partner · 9 April 2024Q30 and Best Ranger Competition partnership to help safeguard Army Rangers with Q-Collars during the 40th anniversary competition at Fort Moore, Georgia. Q-Collars worn to reduce TBI risk during high-impact activities.
  • US Army Medical Research and Development CommandmajorStrategic or Co-development Partner · 26 October 2022$2.8 million contract awarded by USAMRDC to evaluate safety, effectiveness, and field suitability of Q-Collar to help prevent or reduce TBI from blunt force and blast waves in soldiers.
  • Premier Lacrosse LeaguecoreStrategic or Co-development Partner · 21 March 2022Exclusive Brain Injury Protection Partner of PLL since 2022. Q30 equips athletes across all eight PLL teams with Q-Collars. Partnership includes sponsorship of PLL College Draft (presented by Q-Collar) and Inside Lacrosse High School Rankings.
  • Cincinnati Children's Hospital Medical CentercoreStrategic or Co-development PartnerMultiple clinical studies conducted including Human Performance Study, Hockey Study (2014), Football Study (2015-2017), Soccer Study (2016), and tolerability/wearability studies with NFL and CFL players.
  • NorthShore University HealthSystemcoreStrategic or Co-development PartnerDr. Julian Bailes leads research including swine impact safety study and small animal hearing loss studies. Dr. Bailes serves as Q30 Chief Medical Advisor.
  • Boston Children's HospitalcoreStrategic or Co-development PartnerCollaborated on large animal effectiveness study (swine impact model) and research validation for Q-Collar technology.
  • Harvard UniversitycoreStrategic or Co-development PartnerResearch collaboration on closed head rotational head impact protocol in swine model.
  • West Virginia UniversitycoreStrategic or Co-development PartnerPre-clinical and clinical research partner for Q-Collar studies.
  • University of TorontocoreStrategic or Co-development PartnerDr. Joseph Fisher (inventor, professor, Chief Scientist at Thornhill Research) contributed to Q-Collar development and research.
  • Naval Medical Research Center at Walter Reed HospitalcoreStrategic or Co-development PartnerInvestigated whether IJV compression could provide protection against blast-induced TBI in military context.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Q30 Innovations competitors and assessment

Company assessment

Direct peers

  • Unequal Technologies: Developer of protective sports gear using impact-absorbing materials for head, chest, and body protection. Directly comparable to Q30 as a sports protective equipment company serving athletes across multiple contact sports.
  • GuardLab: Mouthguard company with embedded sensors for impact tracking and concussion prevention in contact sports. Comparable to Q30 as a head-impact protection company with presence in NFL, NHL, and college sports markets.
  • Battle Sports Science: Sports protective equipment company specializing in mouthguards, gloves, and pads for football, lacrosse, and hockey. Comparable to Q30 in targeting amateur and professional athletes across the same contact sports categories.
  • VICIS: Football helmet manufacturer using novel impact-mitigation technology to reduce brain injury. Comparable to Q30 as a head-impact protection company focused on reducing concussion risk in contact sports with FDA/state-of-the-art positioning.

Broad incumbents

  • Riddell: Largest US football helmet manufacturer with deep league relationships and broad retail distribution. Comparable to Q30 as an established player in football head protection, but operates at much broader scale as a traditional helmet incumbent.
  • Schutt Sports: Major football helmet and protective equipment manufacturer serving high school, collegiate, and professional markets. Comparable to Q30 in serving the same football head protection category but with broader product portfolio and incumbency.
  • Xenith: Football helmet manufacturer known for novel impact attenuation technology and broad NCAA/NFL distribution. Comparable to Q30 as a head protection company targeting the same football market with complementary rather than directly competing technology.

Emerging players

  • Prevent Biometrics: Developer of sensor-equipped mouthguards for real-time head impact monitoring and concussion detection. Comparable to Q30 in the head-impact protection space but differentiated through diagnostic/monitoring rather than injury mitigation.
  • Orpyx Medical Technologies: Medical wearable company with FDA-cleared sensor-embedded insoles for diabetic neuropathy and pressure monitoring. Comparable to Q30 as a regulated medical device wearable company targeting specific clinical indications.

Others

  • ImPACT Applications: Provider of FDA-cleared neurocognitive testing tools for concussion assessment and management. Comparable to Q30 as a TBI-focused company in the broader brain injury ecosystem, but focused on assessment rather than protection.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Q30 Innovations social profiles

Digital presence

Q30 Innovations compliance and trust

Trust signal

Compliance2 records

Q30 Innovations financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Q30 Innovations leadership team

Management profile

Number of profiles

Profiles8 records

Q30 Innovations subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Q30 Innovations funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Q30 Innovations M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Q30 Innovations

What does Q30 Innovations do?

Q30 Innovations designs, manufactures, and sells the Q-Collar, an FDA-cleared Class 2 medical device worn around the neck that applies mild internal jugular vein compression to increase intracranial blood volume and reduce brain movement ("brain slosh") during impacts. The company offers a standard Q-Collar for athletes ($199), a Tactical version for military/tactical operators ($249), and color-customizable Q-Collar Sleeve accessories ($19.99), sold via direct-to-consumer e-commerce, team sales programs, retail partners, and government procurement.

Is Q30 Innovations a public or private company?

Q30 Innovations is a private company. It is classified as venture growth investor backed and is currently operating.

When was Q30 Innovations founded?

Q30 Innovations was founded in 2011. It employs 11 to 50 people.

Where is Q30 Innovations based?

Q30 Innovations is headquartered in Westport, United States, in the North America region.

How does Q30 Innovations make money?

Two revenue lines are on record. Q-Collar Hardware Sales are the primary driver. The others are team/Institutional Sales.

Who are Q30 Innovations's main competitors?

Direct peers on record are Unequal Technologies, GuardLab, Battle Sports Science and VICIS. Broad incumbents are Riddell, Schutt Sports and Xenith. Emerging players are Prevent Biometrics and Orpyx Medical Technologies. ImPACT Applications is listed as an others.

Does Q30 Innovations have an API?

No public API is recorded for Q30 Innovations.

What industry is Q30 Innovations in?

Q30 Innovations's product category is Brain Protection Medical Devices. Its primary akta.pro industry code is CRAMANAL, Safety Accessories & Wearables Retail (Neck Braces, Hydration, Earplugs), with a secondary code of CRACAIAK, Wearable Accessories & Bands (straps, chargers, cases). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Inc.Q30 Wants the Q-Collar to Become Ordinary. That’s the Hard PartQ30 Innovations aims to change how athletes view brain protection from repetitive head impacts, not just diagnosed concussions. The company's biggest hurdle is shifting public perception, requiring education before adoption. The team spends significant time explaining the science and product fit to improve adoption.Good Morning AmericaA collar might help prevent concussions in sports like soccer: StudyQ30 Innovations developed a specialized neck collar that applies pressure to the back of the neck to create a blood cushion, potentially reducing brain movement during impacts in sports like soccer. A study led by Cincinnati Children's Hospital Medical Center involving high school soccer players showed that wearing the collar prevented signs of brain damage seen in teams not using the device.The SourceOle Miss Running Back Kewan Lacy Signs NIL Deal With Q-CollarOle Miss running back Kewan Lacy has signed a Name, Image and Likeness (NIL) partnership with Q-Collar, developed by Q30 Innovations, to serve as a brand ambassador and wear the device during the 2026 football season. The FDA-cleared neck-worn equipment is designed to limit brain movement and protect against repetitive head impacts, leveraging technology supported by over a decade of research. This agreement marks Lacy's entry into a roster of NFL athletes promoting brain safety in sports.PR NewswireNFL Star Sauce Gardner Partners with Q-Collar to Promote Athlete Safety and Brain HealthNew York Jets cornerback Sauce Gardner has officially partnered with Q30 Innovations as an ambassador for the Q-Collar, a device designed to protect athletes from repetitive head impacts. This partnership follows Gardner's personal use of the device during the 2024 NFL season and aims to raise awareness about brain health among athletes. The collaboration highlights the product's FDA clearance and its growing adoption across various sports.AfrotechThis FDA-Cleared Device, Which Aims To Reduce Traumatic Brain Injury, Was Worn By Sauce Gardner During The 2024 NFL Season - AfroTechNew York Jets cornerback Sauce Gardner has partnered with Q30 Innovations to promote the Q-Collar, an FDA-cleared device designed to reduce traumatic brain injury in athletes. The device, which Gardner wore throughout the 2024 NFL season, applies light pressure to the neck to increase blood volume in the head and minimize brain movement during impact.TheforestscoutA Deep Dive into Q-CollarsQ30 Innovations' Q-Collar, a device designed to reduce head trauma risks in contact sports, has gained adoption among professional athletes and schools following its FDA approval as a medical device. While the company promotes the collar's safety benefits and psychological advantages, scientific research on its effectiveness remains mixed, with some studies showing positive outcomes and others questioning the data reliability.The HinduSRH vs RR, Qualifier 2 IPL 2024: What is Q-Collar, the protective gear worn by Tom Kohler-Cadmore?Rajasthan Royals batter Tom Kohler-Cadmore wore a Q-Collar protective device during the IPL 2024 Qualifier 2 match against Sunrisers Hyderabad. The Q-Collar, developed by Q30 Innovations, is designed to restrict blood flow from the head to provide cushioning and reduce brain injuries from subconcussive impacts.SportstigerWhat is Q-Collar? RR opener Tom Kohler-Cadmore spotted wearing it during PBKS clashRajasthan Royals opener Tom Kohler-Cadmore wore a Q-Collar device during his IPL debut against the Punjab Kings, drawing attention to the safety equipment developed by Q30 Innovations. The Rajasthan Royals successfully chased down the target of 145 runs, with Sam Curran scoring an unbeaten 63 to secure the victory.CricTrackerTom Kohler-Cadmore uses unique device to reduce concussion impactTom Kohler-Cadmore became the first cricketer to wear the Q-Collar, a protective headgear device developed by Q30 Innovations, during his IPL debut for Rajasthan Royals against Punjab Kings. The match resulted in a fourth consecutive defeat for Rajasthan Royals, who lost by five wickets despite a strong batting performance from captain Sam Curran. This incident highlights growing attention on athlete safety devices in cricket as players adopt technology previously common in American football.WisdenExplained: What is the Q-Collar Tom Kohler-Cadmore has been wearing in the Hundred?Trent Rockets wicketkeeper Tom Kohler-Cadmore has been wearing the Q-Collar, a protective neck device developed by Q30 Innovations, during the 2023 Men’s Hundred to mitigate subconcussive head impacts. The device works by slightly constricting blood flow to reduce brain injury risks and is seeing adoption in cricket after gaining traction in other high-impact sports like American football. Q30 Innovations has secured a $2.8 million research contract with the US Army to further study the collar's efficacy in preventing brain injuries from explosions.